Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care
Sign Up to like & getrecommendations! Published in 2020 at "Internal Medicine Journal"
DOI: 10.1111/imj.14779
Abstract: Current guidelines recommend methotrexate (MTX) as a glucocorticoidâsparing agent in patients with polymyalgia rheumatica (PMR) who relapse or suffer glucocorticoid adverse effects, although there is no level 1 evidence to support this recommendation. read more here.
Keywords: methotrexate polymyalgia; polymyalgia rheumatica; routine rheumatology; efficacy methotrexate ... See more keywords